Loading…
Schrödinger, Inc. is projected to rise to $17.16 by 2027, a +13% move from its current price of $15.14. SDGR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $14.83 | $15.14 | $15.46 | +0.02% |
| Aug 3 | $14.71 | $15.15 | $15.60 | +0.05% |
| Aug 4 | $14.61 | $15.15 | $15.71 | +0.07% |
| Aug 5 | $14.53 | $15.15 | $15.80 | +0.10% |
| Aug 6 | $14.47 | $15.16 | $15.88 | +0.12% |
| Aug 7 | $14.41 | $15.16 | $15.96 | +0.15% |
| Aug 8 | $14.35 | $15.17 | $16.03 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.35 | $15.17 | $16.03 | +0.17% |
| Week 2 | $14.05 | $15.19 | $16.43 | +0.34% |
| Week 3 | $13.83 | $15.22 | $16.75 | +0.51% |
| Week 4 | $13.65 | $15.24 | $17.02 | +0.68% |
| Week 5 | $13.49 | $15.27 | $17.28 | +0.85% |
| Week 6 | $13.36 | $15.30 | $17.51 | +1.02% |
| Week 7 | $13.24 | $15.32 | $17.73 | +1.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Schrödinger, Inc. is a healthcare company that develops physics-based computational platforms that enable discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. It operates in two segments, Software and Drug Discovery.
The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates.
Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Schrödinger, Inc. is categorized in Healthcare. The description above centers on its dual-segment business model and ongoing collaboration with a major pharmaceutical partner, within a global reach that includes the United States, the Asia-Pacific, Europe, the Middle East, Africa, and internationally.
Schrödinger, Inc. (SDGR) is a healthcare stock with a current price of $15.60 and a market capitalization of $1.17B. It is ranked 2402 by market capitalization.
Forecasts for 2026 show min $11.07, avg $15.60, max $19.91, with ROI 0 and sentiment NEUTRAL. The 2027 outlook is avg $17.27 with ROI 10.7 and sentiment NEUTRAL, followed by rising targets: 2028 avg $19.79 (ROI 26.9, sentiment BULLISH), 2029 avg $25.43 (ROI 63, sentiment BULLISH), 2030 avg $28.93 (ROI 85.4, sentiment BULLISH).
The forecast continues with 2031 avg $30.69 (ROI 96.7), 2032 avg $33.86 (ROI 117), 2033 avg $34.28 (ROI 119.8), 2034 avg $37.23 (ROI 138.6), and 2035 avg $44.50 (ROI 185.2), all with a BULLISH sentiment. By 2040 the avg is $63.88 (ROI 309.5) and by 2050 the avg is $135.59 (ROI 769.2), with a consistent BULLISH outlook.
The stock exhibits an annualized volatility of 50% and a 30-day technical range that anchors near the mid-$10s, reflecting a history of notable movement against a backdrop of continuing upside projections.
A major floor 26.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.1% away) — a key level to hold.
The nearest ceiling, 14.9% above — a clean break opens room to run.
A major ceiling 20.6% above — clearing it would confirm fresh momentum.
Key SDGR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SDGR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.24 | Sell | $15.21 | Sell |
| MA 10 | $15.14 | Sell | $15.29 | Sell |
| MA 20 | $15.70 | Sell | $15.44 | Sell |
| MA 50 | $15.26 | Sell | $15.07 | Buy |
| MA 100 | $13.68 | Buy | $14.73 | Buy |
| MA 200 | $15.24 | Sell | $15.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.15 | Neutral |
| Stoch RSI (14) | 22.31 | Neutral |
| CCI (20) | -61.50 | Neutral |
| Williams %R (14) | -86.92 | Info |
| MACD (12,26,9) | -0.11 | Sell |
| ROC (12) | -6.95 | Sell |
| Bollinger %B (20,2) | 0.29 | Neutral |
| Stochastic %K (14) | 13.08 | Buy |
| TRIX (15) | 0.01 | Buy |
| Awesome (5,34) | -0.49 | Sell |
| Ultimate (7,14,28) | 46.62 | Neutral |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 15.27 | Sell |
| ADX (14) | 12.58 | Neutral |
| ATR (14) | 0.28 | Info |
The 30-day technical picture is BUllISH. RSI14 sits at 50, with the 50-day moving average (SMA50) at $14.70 and the 200-day moving average (SMA200) at $15.53, indicating a neutral-to-bullish intermediate posture.
Support is quoted at $14.15 and resistance at $17.39, framing a near-term trading path within those levels. The 30-day range spans from $13.03 to $18.68, suggesting a broad, price-coverage window in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.07 | $15.14 | $19.41 | 0% | Neutral | |
| $13.98 | $17.16 | $22.08 | +13% | Neutral | |
| $15.45 | $19.38 | $25.68 | +28% | Bullish | |
| $19.67 | $25.09 | $34.04 | +66% | Bullish | |
| $21.86 | $28.31 | $39.18 | +87% | Bullish | |
| $22.95 | $30.13 | $42.42 | +99% | Bullish | |
| $25.54 | $33.96 | $48.55 | +124% | Bullish | |
| $25.78 | $34.69 | $50.30 | +129% | Bullish | |
| $27.81 | $37.85 | $55.59 | +150% | Bullish | |
| $32.76 | $45.06 | $66.99 | +198% | Bullish | |
| $44.78 | $64.60 | $101.04 | +327% | Bullish | |
| $90.22 | $140.99 | $237.71 | +831% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $11.07 | $15.14 | $18.64 | +0.00% |
| September 2026 | $13.29 | $15.62 | $18.79 | +3.15% |
| October 2026 | $13.11 | $15.48 | $18.78 | -0.89% |
| November 2026 | $13.29 | $15.76 | $19.25 | +1.81% |
| December 2026 | $13.27 | $15.80 | $19.41 | +0.25% |
Click any year to see its month-by-month SDGR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SDGR could reach as high as $19.41, with a base case around $15.14 and support toward $11.07 — roughly 0% from $15.14. A consolidation phase looks the most probable path here.
Expect SDGR to range from $13.98 to $22.08 through 2027. The $17.16 average target implies a +13% move from current prices. That is up +13% on the projected 2026 average. Price action looks broadly range-bound.
The SDGR price prediction for 2028 points to an average of $19.38 (low $15.45, high $25.68) — a potential gain of +28% on today's $15.14. Buyers look set to stay in control over this stretch.
In 2029, SDGR is projected to trade between $19.67 and $34.04, averaging $25.09 — a potential gain of +66% from today's $15.14. That is up +29% on the projected 2028 average. Momentum favours further upside here.
Schrödinger, Inc.'s 2030 outlook centres on $28.31, within a $21.86 to $39.18 range. That is up +13% on the projected 2029 average. That marks a +87% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, SDGR could reach as high as $42.42, with a base case around $30.13 and support toward $22.95 — roughly +99% from $15.14. Momentum favours further upside here.
Expect SDGR to range from $25.54 to $48.55 through 2032. The $33.96 average target implies a +124% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SDGR price prediction for 2033 points to an average of $34.69 (low $25.78, high $50.30) — a potential gain of +129% on today's $15.14. Momentum favours further upside here.
In 2034, SDGR is projected to trade between $27.81 and $55.59, averaging $37.85 — a potential gain of +150% from today's $15.14. That is up +9% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Schrödinger, Inc.'s 2035 outlook centres on $45.06, within a $32.76 to $66.99 range. That is up +19% on the projected 2034 average. That marks a +198% change versus current levels. Momentum favours further upside here.
By 2040, SDGR could reach as high as $101.04, with a base case around $64.60 and support toward $44.78 — roughly +327% from $15.14. Buyers look set to stay in control over this stretch.
Expect SDGR to range from $90.22 to $237.71 through 2050. The $140.99 average target implies a +831% move from current prices. That is up +118% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SDGR today (≈ 66.050198 SDGR) could be worth
$9,312.5
+$8,312.5 (+831%) by 2050 · US Dollar
Based on the average projected SDGR price of $140.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SDGRwould be worth at today's price.
$1,000 invested in SDGR on Jul 31, 2025 (≈ 49.188392 SDGR) would be worth
$744.71
-$255.29 (-25.5%) today · 0.74× · US Dollar
Based on a SDGR entry price of $20.33 vs. today's $15.14.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.97 | $1,011.36 | +1.1% |
| 1 month ago | $16.39 | $923.73 | -7.6% |
| 3 months ago | $12.39 | $1,221.95 | +22.2% |
| 6 months ago | $14.09 | $1,074.52 | +7.5% |
| 1 year ago | $20.33 | $744.71 | -25.5% |
| All time (5.0y) ago | $67.96 | $222.78 | -77.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SDGR forecast.
Our base-case forecast reaches $30.00 around 2031.
Implied market cap at $30.00: $1.97B
The multi-year forecast shows extended upside across the horizon. In 2026 the avg price is $15.60, with 2027 avg $17.27 and ROI 10.7; 2028 avg $19.79 and ROI 26.9; 2029 avg $25.43 and ROI 63; 2030 avg $28.93 and ROI 85.4. These figures point to a rising trend into the late 2020s and early 2030s, supported by a bullish sentiment through 2032 and beyond.
From 2031 through 2035 the averages continue northward to $30.69, $33.86, $34.28, $37.23, and $44.50, with ROIs of 96.7, 117, 119.8, 138.6, and 185.2 respectively, all labeled BULLISH.
The forecast accelerates into 2040 with an avg of $63.88 and ROI of 309.5, and into 2050 with an avg of $135.59 and ROI of 769.2, maintaining a BULLISH sentiment. The implied path suggests substantial upside over the long horizon, with the 2040 and 2050 milestones marking the strongest growth signals, albeit with the usual uncertainty and risk inherent to any long-range projection.
Tap a question to reveal the answer.
2030 avg $28.93; min $21.44; max $42.06; ROI 85.4; sentiment BULLISH.
The forecast shows Neutral in 2026 and 2027, then rising to BULLISH from 2028 onward, with increasing ROIs: 2028 26.9, 2029 63, 2030 85.4, 2031 96.7, 2032 117, 2033 119.8, 2034 138.6, 2035 185.2, 2040 309.5, and 2050 769.2.
Yes. The 2040 max is $107.93 and the 2050 max is $250.68, indicating the capability to exceed $100 in the forecast horizon.
Current price is $15.60 and market cap is $1.17B.
30-day range is $13.03–$18.68; support is $14.15 and resistance is $17.39.
Schrödinger, Inc. Community Discussion
0Share your Schrödinger, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.